|
(11) | EP 0 914 089 A1 |
(12) |
|
|
|
|
|||||||||||||||||||
(54) | USE OF LIPOPHILIC ANTIOXIDANT COMPOUNDS TO PREVENT RETINOID INDUCED, UVA-MEDIATED OXIDATIVE REACTIONS |